Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Access Program With Arimoclomol in US Patients With NPC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04316637
Expanded Access Status : Available
First Posted : March 20, 2020
Last Update Posted : July 27, 2021
Sponsor:
Information provided by (Responsible Party):
Orphazyme

No Study Results Posted on ClinicalTrials.gov for this Study
Expanded Access Status : Available
Primary Completion Date : No date given
Study Completion Date : No date given